Shen Zhao

No ORCID on file · 6 papers in corpus
other 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01341-4

BACKGROUND: Preimplantation embryos in vivo are exposed to various growth factors in the female reproductive tract that are absent in in vitro embryo culture media. Cell-free fat extract exerts antioxidant, anti-ageing, and ovarian function…

observational 2024
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01243-5

BACKGROUND: Among the POSEIDON criteria, group 3 and group 4 have an expected low prognosis. For those patients with inadequate ovary reserve, embryo accumulated from consecutive oocyte retrieval cycles for multiple frozen-thawed embryo tra…

observational 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1093954

BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (CO…

other 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1073164

BACKGROUND: Physicians need an appropriate embryo transfer strategy to address the challenge of reducing multiple birth rates, while maintaining the couples' live birth rate during assisted reproductive technology. METHODS: We included 10,…

other 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1008923

INTRODUCTION: Low molecular-weight heparin (LMWH) plays a role in repeated implantation failure (RIF), but outcomes are controversial. LMWH can potentially modulate local immune responses associated with the establishment and maintenance of…

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.758896

OBJECTIVE: To evaluate the efficiency and validity of cessation of cetrorelix on trigger day during gonadotropin releasing hormone antagonist (GnRH-ant)-controlled ovarian stimulation of in vitro fertilization (IVF) cycles. METHODS: In thi…